Plain-English translation of NCT05476627 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is building a research database of patients whose kidneys have been damaged by metabolic diseases—like diabetes, high blood pressure, high uric acid levels, or obesity. By collecting blood and urine samples and imaging scans from about 200 participants, researchers hope to identify early warning signs of kidney damage and discover what causes some people's kidneys to fail faster than others.
Metabolic diseases are increasingly damaging people's kidneys, but doctors don't yet fully understand why some patients develop severe kidney disease while others don't. This study aims to find early markers of kidney damage and identify which patients are at highest risk, so treatment can start sooner.
You likely qualify if…
You likely don't qualify if…
As a participant, you would visit the research center where you'll provide blood and urine samples and undergo an MRI scan of your kidneys. The study is observational, meaning researchers will study your samples and imaging to look for patterns and risk factors—you won't be taking any new medication as part of this trial. Visits and follow-up timeframe would be discussed with the research team.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
China